BUY Beta Drugs Limited — Nuvama Wealth
Beta Drugs share price target & all analyst calls
⚙︎ Corp-action adjusted
byNuvama WealthHorizon: NA (inferred 1 year)8 Nov 2024via Institutional / Brokerage Research
Entry₹2,194Inferred
Stop lossNot given
At expiry₹1,753.717 Nov 2025, 3:30 pm
Expired-20.07%
Follow Nuvama Wealth for new calls(69% target hit, 144 closed calls)Get alertsWatch BETA for new buy/sell callsGet alertsSee 265 active Long-term picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
No assessed factors in this tip’s window yet.
Other calls on Beta Drugs
All analyst calls on Beta DrugsMore from Nuvama Wealth
- BUY SRF23 Oct 2026 · ~1 year · target ₹2,905 · Active
- BUY Colgate Palmolive (India)23 Oct 2026 · ~1 year · target ₹2,905 · Active
- BUY UltraTech Cement21 Oct 2026 · ~1 year · target ₹14,598 · Active
- BUY Hindustan Zinc21 Oct 2026 · ~1 year · target ₹676 · Active
- BUY Powerica19 Oct 2026 · ~1 year · target ₹700 · Active

